ScholarLens Back to search
1995•Lung CancerRequires access

Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer

Internal Medicine

Open publisher page 24 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Docetaxel, Medicine, Leukopenia, Neutropenia, Internal medicine, Adverse effect, Lung cancer, Phases of clinical research

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer — Research Paper | ScholarLens